Paid Clinical Trials in New Jersey

New Jersey has 1,726 paid clinical trials enrolling now across cities including New Brunswick, Middletown and Basking Ridge. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 8, 2026.

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

1,558 clinical trials

Get a weekly email when new trials open in New Brunswick, NJ.

Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and MCI

for Aging

1 location in East Hanover

Sponsor: Kessler Foundation

Sex: All·Age: 60+·Accepts healthy volunteers

Code: NCT06269939·Recruiting·Listed Feb 2024

Apply to this trial

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for Metastatic Head and Neck Squamous Cell Carcinoma

Sites in Newark +49 more locations

Sponsor: Bicara Therapeutics

Sex: All·Age: 18+

Code: NCT06788990·Phase 2, Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease

for Sickle Cell Disease

Sites in New Brunswick +4 more locations

Sponsor: Sanofi

Sex: All·Age: 2 - 17

Code: NCT07247188·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

for Solid Tumor, Adult

Sites in New Brunswick, Morristown +13 more locations

Sponsor: Pierre Fabre Medicament

Sex: All·Age: 18+

Code: NCT04913285·Phase 1·Recruiting·Listed Jun 2021

Apply to this trial

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

for Asthma

Drug: Depemokimab

Sites in New Brunswick +7 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06979323·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Product Surveillance Registry

for Cardiac Rhythm Disorders

Sites in Morristown, Camden +127 more locations

Sponsor: Medtronic

Sex: All·Age: All ages

Code: NCT01524276·Recruiting·Listed Feb 2012

Apply to this trial

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for Heart Failure and Impaired Kidney Function

Drug: Dapagliflozin

Sites in Jersey City, Somerset +111 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06307652·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

for Ovarian Neoplasms

Drug: Niraparib

Sites in Morristown +8 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT04641247·Phase 2·Recruiting·Listed Nov 2020

Apply to this trial

A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

for Neoplasms, Prostate

Sites in East Brunswick +5 more locations

Sponsor: GlaxoSmithKline

Sex: Male·Age: 18+

Code: NCT06990880·Phase 1, Phase 2·Recruiting·Listed May 2025

Apply to this trial

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for Acute Coronary Syndrome

Sites in Hackensack, Bridgewater +146 more locations

Sponsor: DalCor Pharmaceuticals

Sex: All·Age: 45+

Code: NCT05918861·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for Delayed Graft Function

Sites in Livingston +29 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT06830798·Phase 3·Recruiting·Listed Feb 2025

Apply to this trial

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for HER2-positive Gastric Cancer

Drug: Rilvegostomig

Sites in Summit +44 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06764875·Phase 3·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

for Generalized Myasthenia Gravis

Sites in Neptune City +4 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT07221838·Phase 4·Recruiting·Listed Oct 2025

Apply to this trial

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

for Lupus Nephritis

Sites in Summit +15 more locations

Sponsor: Nkarta, Inc.

Sex: All·Age: 18 - 75

Code: NCT06557265·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

for Head and Neck Squamous Cell Carcinoma

Drug: Petosemtamab

Sites in Hackensack +35 more locations

Sponsor: Merus B.V.

Sex: All·Age: 18+

Code: NCT06525220·Phase 3·Recruiting·Listed Jul 2024

Apply to this trial

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

for Neoplasms

Sites in New Brunswick +14 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06551142·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for Metastatic Non-small Cell Lung Cancer

Drug: Osimertinib

Sites in Morristown, Northfield +25 more locations

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06417814·Phase 3·Recruiting·Listed May 2024

Apply to this trial

Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment

for Eosinophilic Asthma

Sites in Northfield, Union City +29 more locations

Sponsor: AstraZeneca

Sex: All·Age: 12 - 75

Code: NCT06750289·Phase 3·Recruiting·Listed Dec 2024

Apply to this trial

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for Multiple Myeloma

Drug: Belantamab mafodotin

Sites in Hackensack +29 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06679101·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

for Urinary Tract Infections

Sites in Secaucus +5 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18 - 64·Accepts healthy volunteers

Code: NCT06702449·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for Growth Hormone Deficiency

Sites in Morristown +26 more locations

Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All·Age: All ages

Code: NCT05820672·Recruiting·Listed Apr 2023

Apply to this trial

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for Pulmonary Disease, Chronic Obstructive

Drug: Depemokimab

Sites in Sewell, Moorestown +53 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 40 - 80

Code: NCT06961214·Phase 3·Recruiting·Listed May 2025

Apply to this trial

Open-label Extension Study in Participants With Early Alzheimer's Disease

for Alzheimer's Disease

Sites in Toms River +8 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 50 - 85

Code: NCT07105709·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

Study of AZD0754 in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

Sites in Hackensack +12 more locations

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 130

Code: NCT06267729·Phase 1, Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for Growth Hormone Deficiency

Sites in Morristown +26 more locations

Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All·Age: 1 - 18

Code: NCT05775523·Recruiting·Listed Mar 2023

Apply to this trial

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

for Systemic Sclerosis Associated Interstitial Lung Disease

Sites in New Brunswick +23 more locations

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT05878717·Phase 2, Phase 3·Recruiting·Listed May 2023

Apply to this trial

Randomized Withdrawal Study in Patients With Schizophrenia

for Schizophrenia

Sites in Marlton +21 more locations

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT06961968·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age

for Excessive Daytime Sleepiness

Sites in Eatontown +2 more locations

Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT07082829·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

Home Reported Outcomes in PNH

for Paroxysmal Nocturnal Hemoglobinuria

1 location in East Hanover

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 99

Code: NCT06411626·Recruiting·Listed May 2024

Apply to this trial

Home Reported Outcomes in C3G Study

for C3 Glomerulopathy

1 location in East Hanover

Sponsor: Novartis Pharmaceuticals

Sex: All·Age: 18 - 100

Code: NCT07029542·Recruiting·Listed Jun 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

for Persistent Corneal Epithelial Defect

Sites in Palisades Park +20 more locations

Sponsor: Glaukos Corporation

Sex: All·Age: 2+

Code: NCT05966493·Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

for Major Depressive Disorder

Sites in Toms River, Cherry Hill +38 more locations

Sponsor: Axsome Therapeutics, Inc.

Sex: All·Age: 18 - 65

Code: NCT06223880·Phase 4·Recruiting·Listed Jan 2024

Apply to this trial